Published in J Invest Dermatol on June 01, 1990
The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol (1995) 3.16
Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med (1992) 1.12
CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood (2007) 0.97
Identification of cancer-associated gene clusters and genes via clustering penalization. Stat Interface (2009) 0.96
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (2016) 0.77
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell (1993) 13.21
Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (1983) 4.34
Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol (1985) 3.76
Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol (1994) 3.42
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis (1997) 2.97
Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol (1995) 2.41
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol (1996) 2.38
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol (2001) 2.25
Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23
Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature (1990) 2.23
Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol (1998) 2.20
MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci U S A (2000) 2.12
Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology (1984) 2.11
Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand. J Biol Chem (1999) 2.04
Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04
Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate (1999) 2.02
Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol (1998) 1.99
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature (1984) 1.99
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J (1997) 1.82
Integrin alpha(v)beta1 is an adenovirus coreceptor. J Virol (2001) 1.72
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci U S A (1987) 1.68
Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol (1985) 1.58
Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol (1999) 1.57
Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci (1994) 1.55
Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement. J Immunol (1981) 1.50
Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem (2000) 1.43
Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci U S A (1985) 1.43
A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles. J Virol (1999) 1.39
Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine. Nature (1975) 1.39
Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. J Biol Chem (2000) 1.38
Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol (2000) 1.37
Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem (2000) 1.36
Interactions of soluble recombinant integrin alphav beta5 with human adenoviruses. J Virol (1998) 1.36
Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol Prog (1993) 1.34
Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology (1989) 1.32
A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis (1999) 1.31
Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists. Proc Natl Acad Sci U S A (1984) 1.31
Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu Rev Immunol (1988) 1.31
Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein. J Virol (1986) 1.29
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J Biol Chem (1989) 1.26
Biological characteristics and viral susceptibility of an African green monkey kidney cell line (Vero). Proc Soc Exp Biol Med (1969) 1.25
Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci (1993) 1.21
Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med (1988) 1.21
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. J Clin Invest (1982) 1.20
Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis (2007) 1.19
A single amino acid in the adenovirus type 37 fiber confers binding to human conjunctival cells. J Virol (1999) 1.18
Inherited susceptibility to retrovirus-induced transformation of Gardner syndrome cells. Am J Hum Genet (1983) 1.17
Cytopathic and plaque assay of rubella virus in a line of African green monkey kiency cells (Vero). Proc Soc Exp Biol Med (1967) 1.16
A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. Virology (2001) 1.15
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene (1998) 1.15
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Q J Nucl Med Mol Imaging (2004) 1.14
Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N-nitrosoguanidine. Int J Cancer (1977) 1.12
Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero). Proc Soc Exp Biol Med (1967) 1.11
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res (1997) 1.10
Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res (1989) 1.10
Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res (2001) 1.10
Matrix valency regulates integrin-mediated lymphoid adhesion via Syk kinase. J Cell Biol (1999) 1.08
Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther (2001) 1.08
Cycloheximide-dependent reversion of human cells transformed by MSV and chemical carcinogen. Science (1979) 1.07
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07
Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens. Science (1986) 1.07
Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence. J Immunol (1979) 1.06
Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. Oncogene Res (1988) 1.06
Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis (1996) 1.06
Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res (1995) 1.05
Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta5. J Virol (2000) 1.05
Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J Virol (2001) 1.04
Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J Gen Virol (1998) 1.04
Adenosine-sensitive phosphoinositide turnover in a newly established renal cell line. Am J Physiol (1989) 1.04
Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J Biol Chem (1992) 1.01
A novel human cell culture model for the study of familial prostate cancer. Cancer Res (2001) 1.01
Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats. J Virol (1991) 1.01
Complement, viruses, and virus-infected cells. Springer Semin Immunopathol (1983) 1.00
Activated H-ras oncogenes in human kidney tumors. Cancer Res (1988) 0.99
Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J Virol (2001) 0.99
CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J Immunol (1988) 0.99
Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions. J Immunol (1986) 0.98
Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2). J Immunol (1986) 0.96
Malignant human papillomavirus type 16-transformed human keratinocytes exhibit altered expression of extracellular matrix glycoproteins. Cancer Res (1991) 0.95
2,3,7,8-Tetrachlorodibenzo-p-dioxin: molecular mechanism of carcinogenesis and its implication in human in vitro model. Crit Rev Oncol Hematol (1995) 0.94
TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines. Proc Natl Acad Sci U S A (1990) 0.94
Crystallization and preliminary X-ray diffraction analysis of human adenovirus. Virology (2010) 0.94
Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures. Prostate (2000) 0.93
Transformation of rat embryo cells in vitro by chemical carcinogens. Cancer Res (1973) 0.93
Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. Mol Endocrinol (1994) 0.93
Methods to detect and quantitate complement activation. Springer Semin Immunopathol (1983) 0.93
Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350. J Immunol (1988) 0.93
Production of altered cell foci by 3-methylcholanthrene in mouse cells infected with AKR leukemia virus. Proc Natl Acad Sci U S A (1971) 0.92
Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins. Oncogene (2000) 0.92
The relationship between tumorigenicity, growth in agar and fibrinolytic activity in a line of human osteosarcoma cells. Int J Cancer (1975) 0.92
Brief communication: Activation by 5-bromo-2'-deoxyuridine of particles resembling guinea-pig leukemia virus from guinea-pig nonproducer cells. J Natl Cancer Inst (1973) 0.92
Immortalization of mouse bone marrow-derived mast cells with Ad12-SV40 virus. Int Arch Allergy Immunol (1993) 0.92